Company Intelligence Profile
Arcatron Mobility Private Limited
Arcatron Mobility Pvt. Ltd. is a Pune-based consumer-medical/health-tech company that designs, manufactures and retails mobility-assist and ergonomic-support products under its flagship consumer brand "Frido" (frido.com / myfrido.com) and its dedicated mobility line at mobility.myfrido.com.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Arcatron Mobility Private Limited |
|---|---|
| CIN | U29299PN2015PTC155291 |
| PAN | AANCA5219P (Source: Tofler) |
| Status | Active (Private Limited Company), Unlisted |
| Listing | Unlisted |
| Incorporated | 04 June 2015 (Source: Tofler, TheCompanyCheck) |
| ROC | RoC-Pune, Maharashtra (Tofler lists "Maharashtra"; TheCompanyCheck lists "Pune" — same jurisdiction, no conflict) |
| Sector (NIC) | Conflicting classifications across sources: Tofler — "Manufacturing of Machinery & Equipment"; TheCompanyCheck — Primary sector "E-commerce (Online Healthcare Product Retail)", Main activity NIC "Professional, Scientific and Technical Activities (NIC M9)". Actual business (per company/press sources) is design, manufacture and D2C/retail sale of mobility-assist and ergonomic-support devices under the "Frido" brand. |
| Registered address | 403/2, 4th Floor, Amar Tech Park, Patil Nagar, Balewadi, Baner Gaon, Pune, Haveli, Maharashtra, India – 411045 (Source: Tofler, TheCompanyCheck — consistent) |
| Authorized capital | ₹1.66–1.81 Cr (Tofler: ₹1.66 Cr; TheCompanyCheck: ₹1.81 Cr — minor discrepancy, likely reflects different data-pull dates after a capital increase) |
| Paid-up capital | ₹77.69 Lakh (Tofler) / ₹83.28 Lakh (TheCompanyCheck, also stated as issued & subscribed) — minor discrepancy, likely timing difference |
Business Overview
Confirmed- Arcatron Mobility Pvt. Ltd. is a Pune-based consumer-medical/health-tech company that designs, manufactures and retails mobility-assist and ergonomic-support products under its flagship consumer brand "Frido" (frido.com / myfrido.com) and its dedicated mobility line at mobility.myfrido.com
- Product range: electric and manual wheelchairs (incl. carbon-fibre and bariatric variants), transfer aids, mobility scooters, shower/hygiene aids, walking aids, air cushions and bedding aids, plus ergonomic wellness products (orthopedic/seat cushions, cervical pillows, insoles, ergonomic chairs)
- Founded by Ganesh Sonawane after he experienced posture-related back pain while working from home during the pandemic (Source: YourStory, Feb 2024 & 2023)
- Distribution is omnichannel — company website, major e-commerce marketplaces, and 1,000+ offline retail stores across India (Source: Business Today/Pharmabiz, Feb 2024)
- Frido has run marketing tie-ups incl. an IPL 2024 partnership with RCB (per company website press mentions)
- Employee strength ~215 per EPFO data (Source: TheCompanyCheck)
Directors
Partial / conflictingCurrent directors, cross-confirmed by Tofler, TheCompanyCheck and independently corroborated by OrbiMed funding news (Business Today/Pharmabiz, Feb 2024, which names the same two OrbiMed nominees joining the board):
- Ganesh Sharad Sonawane — Founder/Director (shareholder; on board since ~2016, listed as "Officer in Default" on TheCompanyCheck, appointment refreshed 23 Apr 2016)
- Arif Minaj Khan — Director (appointed 04 May 2024)
- Sunny Sharma — Nominee Director, representing OrbiMed (appointed 19 Feb 2024)
- Sumona Chakraborty — Nominee Director, representing OrbiMed (appointed 19 Feb 2024)
DINs: not obtained (Falconebiz, the source flagged as best for DINs, could not be accessed successfully in this pass — its search UI did not return results via available tools).
Financials
Partial / conflictingLatest available (FY ended 31 March 2024, per TheCompanyCheck, labelled "FY2025" data snapshot; standalone, entity-level — no indication of consolidated group accounts):
| Revenue | ₹177.69 Cr (TheCompanyCheck, exact figure) — corroborated by Tofler which shows a revenue band of "₹150–200 Cr" for the same period with 144.54%/145% YoY growth (both sources agree closely) — CONFIRMED (2 sources) |
|---|---|
| EBITDA | not obtained (locked behind premium access on both Tofler and TheCompanyCheck) |
| PAT/Net Profit | not obtained (locked behind premium access) |
| Net worth | growth of 128.61% YoY reported (Tofler); absolute figure not obtained |
| Borrowings | declined ~73.0% YoY (Tofler); absolute figure not obtained |
| Auditor | Narahari V Dixit & Co. (TheCompanyCheck) |
Overall status: partial — revenue confirmed, profitability/net-worth/borrowings figures not obtained.
Funding
ConfirmedMultiple funding rounds identified via news sources (WebSearch budget was exhausted for this session; the below was sourced via Bing News search executed through the browser tool, cross-checked against original publisher pages): 1. ~2017 — Seed/early round from Indian Angel Network (IAN), undisclosed amount; investors named: Sudhir Mehta, Harish Mehta, Ketan Mehta (per VCCircle/Business Line headlines, ~9 years old at time of search — publication dates not independently re-confirmed). 2. 08 Apr 2023 — ₹12.5 Cr raised, led by BL Taparia Family Office, with co-investor(s) including Chona (Family Office) (Source: Hindustan Times, "Bits and Bytes" Pune startup column, dated 08/04/2023 per Bing News index; full article could not be fetched directly due to site access restrictions, so details are per search-result snippet only). 3. 15–20 Feb 2024 — Growth-capital investment from OrbiMed (global healthcare-focused investment firm); amount not disclosed in any source found. Existing investors BL Taparia Family Office, Chona Family Office and MGA Ventures also participated/continued. Use of funds: R&D, new product development, branding/marketing. OrbiMed representatives Dr. Sunny Sharma and Sumona Chakraborty joined the board as nominee directors (this matches the current-directors list independently, strengthening confidence). Sources: Business Today (15 Feb 2024) and Pharmabiz (20 Feb 2024), both fetched directly and consistent with each other. No valuation or post-money figures disclosed in any source. Total funding-to-date figure not obtained.
Charges & Borrowings
Confirmed- Confirmed, 2 sources agree directionally: TheCompanyCheck reports 8 total historical charge records, all now satisfied, aggregating ₹10.85 Cr satisfied and ₹0 currently open
- Tofler (checked live) states "the company has no registered charges" (i.e., no currently active/open charges), consistent with all prior charges having been satisfied
- No lender names or individual charge amounts/dates were obtainable from the free-tier views
Competitors
Partial / conflictingPartial / informed-estimate (not sourced from a dedicated peer-comparison page for this company; based on category knowledge of the Indian mobility-assist/ergonomic-wellness device market):
- Karma Healthcare Ltd — wheelchairs and mobility aids; established/larger-scale manufacturer, broader hospital+retail distribution.
- Vissco Rehabilitation Systems — orthopedic supports, mobility aids; long-established, similar-to-larger scale.
- Tynor Orthotics Ltd — orthopedic and rehabilitation products; larger, more institution-oriented.
- Dolphy India — mobility and daily-living aid products; comparable D2C/online-retail scale.
- Escort Mobility / Praxis Regenharv — motorized wheelchairs/mobility scooters niche players; smaller-to-comparable scale.
- Wakefit / TheSleepCompany (adjacent, ergonomic sleep/seating category rather than direct mobility-aid competitors) — larger-scale D2C peers in the broader "ergonomic wellness" space Frido also plays in.
Note: this list should be treated as directional category mapping, not a verified/sourced competitive-set — flag for follow-up sourcing if precision is required for the pSEO page.
Frequently Asked Questions
What does Arcatron Mobility Private Limited do?
What is the CIN of Arcatron Mobility Private Limited?
Where is Arcatron Mobility Private Limited registered?
When was Arcatron Mobility Private Limited incorporated?
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.